Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026)
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | 709.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 554.14 Mn |
| Mar 31, 2026 | 518.26 Mn |
| Dec 31, 2025 | 513.15 Mn |
| Sep 30, 2025 | 501.75 Mn |
| Jun 30, 2025 | 499.79 Mn |
| Mar 31, 2025 | 498.68 Mn |
| Dec 31, 2024 | 502.78 Mn |
| Sep 30, 2024 | 507.00 Mn |
| Jun 30, 2024 | 517.16 Mn |
| Mar 31, 2024 | 523.46 Mn |
| Dec 31, 2023 | 526.06 Mn |
| Sep 30, 2023 | 525.59 Mn |
| Jun 30, 2023 | 527.47 Mn |
| Mar 31, 2023 | 523.03 Mn |
| Dec 31, 2022 | 523.49 Mn |
| Sep 30, 2022 | 514.82 Mn |
| Jun 30, 2022 | 508.20 Mn |
| Mar 31, 2022 | 504.39 Mn |
| Dec 31, 2021 | 501.96 Mn |
| Sep 30, 2021 | 484.94 Mn |